Genetic engineering drugs has applications in research, medicine, agriculture, and industry and can be used on a broad range of plants, animals and microorganisms. In medicine, genetic engineering has been used to mass-produce human albumin, human growth hormones, follistim (for treating infertility), insulin, antihemophilic factors, monoclonal antibodies, vaccines, and many other drugs. In research, Organisms are genetically modified in experiments to learn more about the roles of specific genes. Transforming microorganisms such as bacteria or yeast, or insect mammalian cells with a gene coding for a useful protein, are examples of industrial applications. The protein can be produced in large amounts by fermenting the transformed organism in bioreactors and then purifying the protein.
MARKET DYNAMICS
Factors driving the growth of the genetic engineering drug market are the growing development of novel technologies in genome engineering, coupled with rising funding and investments for the development and research of new genetic engineering technologies. However, the high cost of genome engineering technology and needs high skilled researchers, which limits its adoption rate is expected to hamper the growth of the market. Moreover, increasing strategic collaboration for genome engineering drugs is anticipated to boost the market growth.
MARKET SCOPE
The "Genetic Engineering Drug Market Analysis to 2028" is a specialized and in-depth study of the healthcare industry with a special focus on the global market trend analysis. The report aims to provide an overview of genetic engineering drug market with detailed market segmentation by product type and end user. The genetic engineering drug market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the leading players in genetic engineering drug market and offers key trends and opportunities in the market.
MARKET SEGMENTATION
The genetic engineering drug market is segmented on the basis of product type and end users. Based on product type, the market is segmented as monoclonal antibody, recombinant human erythropoietin, recombinant human interferon, recombinant human growth hormone, and recombinant human insulin. On the basis of end users, the market is categorized as pharmaceutical industries, academic institutes agriculture, and others.
REGIONAL FRAMEWORK
The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the genetic engineering drug market based on various segments. It also provides market size and forecast estimates from year 2020 to 2028 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The genetic engineering drug market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 18 countries globally along with current trend and opportunities prevailing in the region.
The report analyzes factors affecting genetic engineering drug market from both demand and supply side and further evaluates market dynamics affecting the market during forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors effecting the genetic engineering drug market in these regions.
Have a question?
Akshay
Akshay will walk you through a 15-minute call to present the report’s content and answer all queries if you have any.
Speak to Analyst
- Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
- Request discounts available for Start-Ups & Universities
The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the genetic engineering drug market based on various segments. It also provides market size and forecast estimates from year 2020 to 2028 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The genetic engineering drug market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 18 countries globally along with current trend and opportunities prevailing in the region.
The report analyzes factors affecting genetic engineering drug market from both demand and supply side and further evaluates market dynamics affecting the market during forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors effecting the genetic engineering drug market in these regions.
MARKET PLAYERS
The report covers key developments in the genetic engineering drug market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies witnessed in the market were acquisitions, and partnership & collaborations. These activities have paved way for expansion of business and customer base of market players. The market players from genetic engineering drug market are anticipated to have lucrative growth opportunities in the future with the rising demand for genetic engineering drug in the global market. Below mentioned is the list of few companies engaged in the genetic engineering drug market.
The report also includes the profiles of key players in genetic engineering drug market along with their SWOT analysis and market strategies. In addition, the report focuses on leading industry players with information such as company profiles, components and services offered, financial information of last 3 years, key development in past five years.
- Shanghai Lansheng Guojian Pharmaceutical
- Biotech Pharmaceutical
- GeneScience Pharmaceuticals
- Beijing SL Pharmaceutical
- Anhui Anke Biotechnology
- 3SBio
- Jiangsu Sihuan Bioengineering
- Tonghua Dongbao Pharmaceutical
- Shenzhen Neptunus Interlong Bio-Technique
- Others
The Insight Partner's dedicated research and analysis team consists of experienced professionals with advanced statistical expertise and offers various customization options in the existing study.
- Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
- Request discounts available for Start-Ups & Universities
Report Coverage
Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends
Segment Covered
This text is related
to segments covered.
Regional Scope
North America, Europe, Asia Pacific, Middle East & Africa, South & Central America
Country Scope
This text is related
to country scope.
1. INTRODUCTION
1.1. SCOPE OF THE STUDY
1.2. THE INSIGHT PARTNERS RESEARCH REPORT GUIDANCE
1.3. MARKET SEGMENTATION
1.3.1 Genetic Engineering Drug Market - By Product Type
1.3.2 Genetic Engineering Drug Market - By End users
1.3.3 Genetic Engineering Drug Market - By Region
1.3.3.1 By Country
2. KEY TAKEAWAYS
3. RESEARCH METHODOLOGY
4. GENETIC ENGINEERING DRUG MARKET LANDSCAPE
4.1. OVERVIEW
4.2. PEST ANALYSIS
4.2.1 North America - Pest Analysis
4.2.2 Europe - Pest Analysis
4.2.3 Asia-Pacific - Pest Analysis
4.2.4 Middle East and Africa - Pest Analysis
4.2.5 South and Central America - Pest Analysis
4.3. EXPERT OPINIONS
5. GENETIC ENGINEERING DRUG MARKET - KEY MARKET DYNAMICS
5.1. KEY MARKET DRIVERS
5.2. KEY MARKET RESTRAINTS
5.3. KEY MARKET OPPORTUNITIES
5.4. FUTURE TRENDS
5.5. IMPACT ANALYSIS OF DRIVERS AND RESTRAINTS
6. GENETIC ENGINEERING DRUG MARKET - GLOBAL MARKET ANALYSIS
6.1. GENETIC ENGINEERING DRUG - GLOBAL MARKET OVERVIEW
6.2. GENETIC ENGINEERING DRUG - GLOBAL MARKET AND FORECAST TO 2028
6.3. MARKET POSITIONING/MARKET SHARE
7. GENETIC ENGINEERING DRUG MARKET - REVENUE AND FORECASTS TO 2028 - PRODUCT TYPE
7.1. OVERVIEW
7.2. PRODUCT TYPE MARKET FORECASTS AND ANALYSIS
7.3. MONOCLONAL ANTIBODY
7.3.1. Overview
7.3.2. Monoclonal Antibody Market Forecast and Analysis
7.4. RECOMBINANT HUMAN ERYTHROPOIETIN
7.4.1. Overview
7.4.2. Recombinant Human Erythropoietin Market Forecast and Analysis
7.5. RECOMBINANT HUMAN INTERFERON
7.5.1. Overview
7.5.2. Recombinant Human Interferon Market Forecast and Analysis
7.6. RECOMBINANT HUMAN GROWTH HORMONE
7.6.1. Overview
7.6.2. Recombinant Human Growth Hormone Market Forecast and Analysis
7.7. RECOMBINANT HUMAN INSULIN
7.7.1. Overview
7.7.2. Recombinant Human Insulin Market Forecast and Analysis
8. GENETIC ENGINEERING DRUG MARKET - REVENUE AND FORECASTS TO 2028 - END USERS
8.1. OVERVIEW
8.2. END USERS MARKET FORECASTS AND ANALYSIS
8.3. PHARMACEUTICAL INDUSTRIES
8.3.1. Overview
8.3.2. Pharmaceutical Industries Market Forecast and Analysis
8.4. ACADEMIC INSTITUTES
8.4.1. Overview
8.4.2. Academic Institutes Market Forecast and Analysis
8.5. AGRICULTURE
8.5.1. Overview
8.5.2. Agriculture Market Forecast and Analysis
8.6. OTHERS
8.6.1. Overview
8.6.2. Others Market Forecast and Analysis
9. GENETIC ENGINEERING DRUG MARKET REVENUE AND FORECASTS TO 2028 - GEOGRAPHICAL ANALYSIS
9.1. NORTH AMERICA
9.1.1 North America Genetic Engineering Drug Market Overview
9.1.2 North America Genetic Engineering Drug Market Forecasts and Analysis
9.1.3 North America Genetic Engineering Drug Market Forecasts and Analysis - By Product Type
9.1.4 North America Genetic Engineering Drug Market Forecasts and Analysis - By End users
9.1.5 North America Genetic Engineering Drug Market Forecasts and Analysis - By Countries
9.1.5.1 United States Genetic Engineering Drug Market
9.1.5.1.1 United States Genetic Engineering Drug Market by Product Type
9.1.5.1.2 United States Genetic Engineering Drug Market by End users
9.1.5.2 Canada Genetic Engineering Drug Market
9.1.5.2.1 Canada Genetic Engineering Drug Market by Product Type
9.1.5.2.2 Canada Genetic Engineering Drug Market by End users
9.1.5.3 Mexico Genetic Engineering Drug Market
9.1.5.3.1 Mexico Genetic Engineering Drug Market by Product Type
9.1.5.3.2 Mexico Genetic Engineering Drug Market by End users
9.2. EUROPE
9.2.1 Europe Genetic Engineering Drug Market Overview
9.2.2 Europe Genetic Engineering Drug Market Forecasts and Analysis
9.2.3 Europe Genetic Engineering Drug Market Forecasts and Analysis - By Product Type
9.2.4 Europe Genetic Engineering Drug Market Forecasts and Analysis - By End users
9.2.5 Europe Genetic Engineering Drug Market Forecasts and Analysis - By Countries
9.2.5.1 Germany Genetic Engineering Drug Market
9.2.5.1.1 Germany Genetic Engineering Drug Market by Product Type
9.2.5.1.2 Germany Genetic Engineering Drug Market by End users
9.2.5.2 France Genetic Engineering Drug Market
9.2.5.2.1 France Genetic Engineering Drug Market by Product Type
9.2.5.2.2 France Genetic Engineering Drug Market by End users
9.2.5.3 Italy Genetic Engineering Drug Market
9.2.5.3.1 Italy Genetic Engineering Drug Market by Product Type
9.2.5.3.2 Italy Genetic Engineering Drug Market by End users
9.2.5.4 Spain Genetic Engineering Drug Market
9.2.5.4.1 Spain Genetic Engineering Drug Market by Product Type
9.2.5.4.2 Spain Genetic Engineering Drug Market by End users
9.2.5.5 United Kingdom Genetic Engineering Drug Market
9.2.5.5.1 United Kingdom Genetic Engineering Drug Market by Product Type
9.2.5.5.2 United Kingdom Genetic Engineering Drug Market by End users
9.2.5.6 Rest of Europe Genetic Engineering Drug Market
9.2.5.6.1 Rest of Europe Genetic Engineering Drug Market by Product Type
9.2.5.6.2 Rest of Europe Genetic Engineering Drug Market by End users
9.3. ASIA-PACIFIC
9.3.1 Asia-Pacific Genetic Engineering Drug Market Overview
9.3.2 Asia-Pacific Genetic Engineering Drug Market Forecasts and Analysis
9.3.3 Asia-Pacific Genetic Engineering Drug Market Forecasts and Analysis - By Product Type
9.3.4 Asia-Pacific Genetic Engineering Drug Market Forecasts and Analysis - By End users
9.3.5 Asia-Pacific Genetic Engineering Drug Market Forecasts and Analysis - By Countries
9.3.5.1 Australia Genetic Engineering Drug Market
9.3.5.1.1 Australia Genetic Engineering Drug Market by Product Type
9.3.5.1.2 Australia Genetic Engineering Drug Market by End users
9.3.5.2 China Genetic Engineering Drug Market
9.3.5.2.1 China Genetic Engineering Drug Market by Product Type
9.3.5.2.2 China Genetic Engineering Drug Market by End users
9.3.5.3 India Genetic Engineering Drug Market
9.3.5.3.1 India Genetic Engineering Drug Market by Product Type
9.3.5.3.2 India Genetic Engineering Drug Market by End users
9.3.5.4 Japan Genetic Engineering Drug Market
9.3.5.4.1 Japan Genetic Engineering Drug Market by Product Type
9.3.5.4.2 Japan Genetic Engineering Drug Market by End users
9.3.5.5 South Korea Genetic Engineering Drug Market
9.3.5.5.1 South Korea Genetic Engineering Drug Market by Product Type
9.3.5.5.2 South Korea Genetic Engineering Drug Market by End users
9.3.5.6 Rest of Asia-Pacific Genetic Engineering Drug Market
9.3.5.6.1 Rest of Asia-Pacific Genetic Engineering Drug Market by Product Type
9.3.5.6.2 Rest of Asia-Pacific Genetic Engineering Drug Market by End users
9.4. MIDDLE EAST AND AFRICA
9.4.1 Middle East and Africa Genetic Engineering Drug Market Overview
9.4.2 Middle East and Africa Genetic Engineering Drug Market Forecasts and Analysis
9.4.3 Middle East and Africa Genetic Engineering Drug Market Forecasts and Analysis - By Product Type
9.4.4 Middle East and Africa Genetic Engineering Drug Market Forecasts and Analysis - By End users
9.4.5 Middle East and Africa Genetic Engineering Drug Market Forecasts and Analysis - By Countries
9.4.5.1 South Africa Genetic Engineering Drug Market
9.4.5.1.1 South Africa Genetic Engineering Drug Market by Product Type
9.4.5.1.2 South Africa Genetic Engineering Drug Market by End users
9.4.5.2 Saudi Arabia Genetic Engineering Drug Market
9.4.5.2.1 Saudi Arabia Genetic Engineering Drug Market by Product Type
9.4.5.2.2 Saudi Arabia Genetic Engineering Drug Market by End users
9.4.5.3 U.A.E Genetic Engineering Drug Market
9.4.5.3.1 U.A.E Genetic Engineering Drug Market by Product Type
9.4.5.3.2 U.A.E Genetic Engineering Drug Market by End users
9.4.5.4 Rest of Middle East and Africa Genetic Engineering Drug Market
9.4.5.4.1 Rest of Middle East and Africa Genetic Engineering Drug Market by Product Type
9.4.5.4.2 Rest of Middle East and Africa Genetic Engineering Drug Market by End users
9.5. SOUTH AND CENTRAL AMERICA
9.5.1 South and Central America Genetic Engineering Drug Market Overview
9.5.2 South and Central America Genetic Engineering Drug Market Forecasts and Analysis
9.5.3 South and Central America Genetic Engineering Drug Market Forecasts and Analysis - By Product Type
9.5.4 South and Central America Genetic Engineering Drug Market Forecasts and Analysis - By End users
9.5.5 South and Central America Genetic Engineering Drug Market Forecasts and Analysis - By Countries
9.5.5.1 Brazil Genetic Engineering Drug Market
9.5.5.1.1 Brazil Genetic Engineering Drug Market by Product Type
9.5.5.1.2 Brazil Genetic Engineering Drug Market by End users
9.5.5.2 Argentina Genetic Engineering Drug Market
9.5.5.2.1 Argentina Genetic Engineering Drug Market by Product Type
9.5.5.2.2 Argentina Genetic Engineering Drug Market by End users
9.5.5.3 Rest of South and Central America Genetic Engineering Drug Market
9.5.5.3.1 Rest of South and Central America Genetic Engineering Drug Market by Product Type
9.5.5.3.2 Rest of South and Central America Genetic Engineering Drug Market by End users
10. IMPACT OF COVID-19 PANDEMIC ON GLOBAL GENETIC ENGINEERING DRUG MARKET
10.1 North America
10.2 Europe
10.3 Asia-Pacific
10.4 Middle East and Africa
10.5 South and Central America
11. INDUSTRY LANDSCAPE
11.1. MERGERS AND ACQUISITIONS
11.2. AGREEMENTS, COLLABORATIONS AND JOIN VENTURES
11.3. NEW PRODUCT LAUNCHES
11.4. EXPANSIONS AND OTHER STRATEGIC DEVELOPMENTS
12. GENETIC ENGINEERING DRUG MARKET, KEY COMPANY PROFILES
12.1. SHANGHAI LANSHENG GUOJIAN PHARMACEUTICAL
12.1.1. Key Facts
12.1.2. Business Description
12.1.3. Products and Services
12.1.4. Financial Overview
12.1.5. SWOT Analysis
12.1.6. Key Developments
12.2. BIOTECH PHARMACEUTICAL
12.2.1. Key Facts
12.2.2. Business Description
12.2.3. Products and Services
12.2.4. Financial Overview
12.2.5. SWOT Analysis
12.2.6. Key Developments
12.3. GENESCIENCE PHARMACEUTICALS
12.3.1. Key Facts
12.3.2. Business Description
12.3.3. Products and Services
12.3.4. Financial Overview
12.3.5. SWOT Analysis
12.3.6. Key Developments
12.4. BEIJING SL PHARMACEUTICAL
12.4.1. Key Facts
12.4.2. Business Description
12.4.3. Products and Services
12.4.4. Financial Overview
12.4.5. SWOT Analysis
12.4.6. Key Developments
12.5. ANHUI ANKE BIOTECHNOLOGY
12.5.1. Key Facts
12.5.2. Business Description
12.5.3. Products and Services
12.5.4. Financial Overview
12.5.5. SWOT Analysis
12.5.6. Key Developments
12.6. 3SBIO
12.6.1. Key Facts
12.6.2. Business Description
12.6.3. Products and Services
12.6.4. Financial Overview
12.6.5. SWOT Analysis
12.6.6. Key Developments
12.7. JIANGSU SIHUAN BIOENGINEERING
12.7.1. Key Facts
12.7.2. Business Description
12.7.3. Products and Services
12.7.4. Financial Overview
12.7.5. SWOT Analysis
12.7.6. Key Developments
12.8. TONGHUA DONGBAO PHARMACEUTICAL
12.8.1. Key Facts
12.8.2. Business Description
12.8.3. Products and Services
12.8.4. Financial Overview
12.8.5. SWOT Analysis
12.8.6. Key Developments
12.9. SHENZHEN NEPTUNUS INTERLONG BIO-TECHNIQUE
12.9.1. Key Facts
12.9.2. Business Description
12.9.3. Products and Services
12.9.4. Financial Overview
12.9.5. SWOT Analysis
12.9.6. Key Developments
12.10. OTHERS
12.10.1. Key Facts
12.10.2. Business Description
12.10.3. Products and Services
12.10.4. Financial Overview
12.10.5. SWOT Analysis
12.10.6. Key Developments
13. APPENDIX
13.1. ABOUT THE INSIGHT PARTNERS
13.2. GLOSSARY OF TERMS
1. Shanghai Lansheng Guojian Pharmaceutical
2. Biotech Pharmaceutical
3. GeneScience Pharmaceuticals
4. Beijing SL Pharmaceutical
5. Anhui Anke Biotechnology
6. 3SBio
7. Jiangsu Sihuan Bioengineering
8. Tonghua Dongbao Pharmaceutical
9. Shenzhen Neptunus Interlong Bio-Technique
10. Others
The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.
- Data Collection and Secondary Research:
As a market research and consulting firm operating from a decade, we have published many reports and advised several clients across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.
Several associations trade associates, technical forums, institutes, societies and organizations are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in the last 3 years are scrutinized and analyzed to understand the current market trends.
- Primary Research:
The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.
For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/Sales Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.
A typical research interview fulfils the following functions:
- Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
- Validates and strengthens in-house secondary research findings
- Develops the analysis team’s expertise and market understanding
Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:
- Industry participants: VPs, business development managers, market intelligence managers and national sales managers
- Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.
Below is the breakup of our primary respondents by company, designation, and region:
Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.
- Data Analysis:
Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.
- 3.1 Macro-Economic Factor Analysis:
We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.
- 3.2 Country Level Data:
Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.
- 3.3 Company Profile:
The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.
- 3.4 Developing Base Number:
Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.
- Data Triangulation and Final Review:
The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.
We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.
We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.
Trends and growth analysis reports related to Genetic Engineering Drug Market
Apr 2024
Bioprocessing Market
Size and Forecast (2021 - 2031), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Product (Instruments, and Consumables and Accessories), Scale of Operation (Commercial Operations and Clinical Operations), Process (Downstream Bioprocess and Upstream Bioprocess), Application (Monoclonal Antibodies, Vaccines, Recombinant Protein, Cell and Gene Therapy, and Others), End User (Biopharmaceutical Companies, Contract Manufacturing Organization, and Others), and Geography (North America, Europe, Asia Pacific, South & Central America, and Middle East & Africa)
Apr 2024
Bioproduction Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Product (Biologics and Biosimilars, Vaccines, Cell and Gene Therapies, Nucleic Acid Therapeutics, and Others), Application (Rheumatoid Arthritis, Hematological Disorders, Cancer, Diabetes, Cardiovascular Diseases, and Others), Equipment (Upstream Equipment, Downstream Equipment, Bioreactors, and Consumables and Accessories), End User (Biopharmaceutical Companies, Contract Manufacturing Organizations, and Others), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America)
Apr 2024
ELISA Diagnostic Test Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Adoption (Human and Veterinary), Test Type (Sandwich ELISA, Indirect ELISA, Competitive ELISA, and Multiple & Portable ELISA), Application (Autoimmune Diseases, Infectious Diseases, Cancer Diagnosis, Protein Quantification, and Others), End User (Hospitals & Diagnostic Centers, Pharmaceutical & Biotechnology Companies, Veterinary Hospitals & Diagnostic Laboratories, and Others), and Geography (North America, Europe, Asia Pacific, South & Central America, and Middle East & Africa)
Apr 2024
Swine Diagnostics Market
Size and Forecasts (2022 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Product Type [Immunoassays Kits, PCR Kits, Hemagglutination Inhibition (HI), and Others], Sample Type (Blood, Oral Fluids, Nasal Swabs, Tissue Samples, and Others), Disease [African Swine Fever (ASF)/Classical Swine Fever (CSF), Respiratory Diseases, Porcine Circovirus, Porcine Epidemic Diarrhea, Swine Dysentery, and Others], End User (Veterinary Hospitals, Veterinary Clinics, and Other End Users), and Geography
Apr 2024
Microbial Identification Methods Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Method (Genotypic, Phenotypic, and Proteotypic), Type (Bacterial Identification System, Microbial Enumeration System, Bacterial Resistance Identification Systems, Microbiology Analyzer, and Others), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and Latin America)
Apr 2024
Biopharmaceuticals Market
Forecast to 2028 - COVID-19 Impact and Global Analysis By Product Type (Monoclonal Antibodies, Recombinant Vaccines, Conventional Vaccines, Recombinant Growth Factors, Purified Proteins, Recombinant Proteins, Recombinant Hormones, Recombinant Enzymes, Cell & Gene Therapies, Cytokines/Interferon/Interleukins, and Others) and Application (Oncology, Inflammatory & Infectious Disease, Autoimmune Disorders, Metabolic Disorders, Hormonal Disorders & Growth Failure, Cardiovascular Diseases, Neurological Diseases, and Others)
Apr 2024
GMP Cell Therapy Consumables Market
Forecast to 2028 - COVID-19 Impact and Global Analysis by Product (Kits, Reagents/Molecular Biology Reagents, Growth Factors/Cytokines and Interleukins, and Others), Cell Therapy (NK Cell Therapy, Stem Cell Therapy, T-Cell Therapy, and Others), Process (Cell Collection and Characterization/Sorting and Separation, Cell Culture and Expansion/Preparation, Cryopreservation, Cell Processing and Formulation, Cell Isolation and Activation, Cell Distribution/Handling, Process Monitoring and Control/Readministration/Quality Assurance, and Others), and End Use (Clinical, Commercial, and Research)
Apr 2024